Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
lung cancer
Jul 3, 2024, 02:46 |
Blog
Malak Alharbi: Stephen V. Liu discusses treatment algorithm for early-stage NSCLC
Malak Alharbi, Hematology/Oncology Fellow at Roswell Park, made the following post on X: "Dr. Stephen…
Jul 2, 2024, 15:06 |
Insight
Estela Rodriguez: Celebrating FLASCO day
Estela Rodriguez shared a post on X: “Celebrating FLASCO day with old and new friends…
Jul 2, 2024, 14:57 |
Blog
Wafik S. El-Deiry: My second talk at the DAVA Oncology 3rd Global Thoracic Malignancies Summit
Wafik S. El-Deiry shared on LinkedIn: “Gave my second talk at the DAVA Oncology 3rd…
Jul 2, 2024, 08:55 |
Blog
Mark Wildgust: Another incredible milestone for our JNJOncology team!
Mark Wildgust, Vice President, Global Medical Affairs, Oncology at The Janssen Pharmaceutical Companies of Johnson and…
Jul 2, 2024, 08:34 |
Blog
Aruni Ghose: Looking forward to collaborate more on Geriatric Oncology presentations around UK
Aruni Ghose shared a post by Akash Maniam, Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared…
Jul 1, 2024, 17:27 |
Blog
Bernard A. Fox: A new generation of immunotherapy clinical trials
Bernard A. Fox, Co-Founder and CEO of UbiVac shared on LinkedIn: “Great to be in…
Jul 1, 2024, 15:15 |
Blog
Cesar Perez: Increasing the Impact of Immunotherapy
Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and…
Jul 1, 2024, 15:01 |
Blog
Antonio Passaro: A significant milestone for the advancement and understanding of EGFR-mutated NSCLC
Antonio Passaro, shared a post on LinkedIn: "I am honored to have contributed, as investigator…
Jul 1, 2024, 03:08 |
Blog
Stephen V Liu: Phase III Adjuvant BR.31 study does not meet primary endpoint
Stephen V Liu shared on X: “Phase III ADJUVANT BR.31 study does not meet primary…
Jul 1, 2024, 02:31 |
Blog
Biagio Ricciuti receives a 2024 IASLC YIA to develop new therapies for KRAS amplified NSCLC
Biagio Ricciuti shared a post by Dana-Farber News, on X: "Thrilled to receive a 2024…
96
97
98
99
100
All:
1579
Posts:
971 - 980
Tsetsegsaikhan Batmunkh: Honored to be nominated for the board of directors of the UICC
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
MASCC24 Highlights: The Ideal Location for Care Varies According to Disease, Patient and Family Characteristics
Facebook
RSS Feed
Twitter
Linkedin
Youtube